Kim HS - Search Results

1

Yttrium-90 radioembolization for unresectable standard-chemorefractory intrahepatic cholangiocarcinoma: survival, efficacy, and safety study.

Rafi S, Piduru SM, El-Rayes B, Kauh JS, Kooby DA, Sarmiento JM, Kim HS. Rafi S, et al. Among authors: kim hs. Cardiovasc Intervent Radiol. 2013 Apr;36(2):440-8. doi: 10.1007/s00270-012-0463-4. Epub 2012 Sep 7. Cardiovasc Intervent Radiol. 2013. PMID: 22956045

2

Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis.

Dhanasekaran R, West JK, Gonzales PC, Subramanian R, Parekh S, Spivey JR, Martin LG, Kim HS. Dhanasekaran R, et al. Among authors: kim hs. Am J Gastroenterol. 2010 Mar;105(3):635-41. doi: 10.1038/ajg.2009.634. Epub 2009 Nov 10. Am J Gastroenterol. 2010. PMID: 19904245

3

Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma.

Kooby DA, Egnatashvili V, Srinivasan S, Chamsuddin A, Delman KA, Kauh J, Staley CA 3rd, Kim HS. Kooby DA, et al. Among authors: kim hs. J Vasc Interv Radiol. 2010 Feb;21(2):224-30. doi: 10.1016/j.jvir.2009.10.013. Epub 2009 Dec 21. J Vasc Interv Radiol. 2010. PMID: 20022765

4

Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC).

Dhanasekaran R, Kooby DA, Staley CA, Kauh JS, Khanna V, Kim HS. Dhanasekaran R, et al. Among authors: kim hs. J Surg Oncol. 2010 May 1;101(6):476-80. doi: 10.1002/jso.21522. J Surg Oncol. 2010. PMID: 20213741

5

Prognostic factors for survival in patients with unresectable hepatocellular carcinoma undergoing chemoembolization with doxorubicin drug-eluting beads: a preliminary study.

Dhanasekaran R, Kooby DA, Staley CA, Kauh JS, Khanna V, Kim HS. Dhanasekaran R, et al. Among authors: kim hs. HPB (Oxford). 2010 Apr;12(3):174-80. doi: 10.1111/j.1477-2574.2009.00138.x. HPB (Oxford). 2010. PMID: 20590884 Free PMC article.

6

The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma.

Dhanasekaran R, Khanna V, Kooby DA, Spivey JR, Parekh S, Knechtle SJ, Carew JD, Kauh JS, Kim HS. Dhanasekaran R, et al. Among authors: kim hs. J Vasc Interv Radiol. 2010 Aug;21(8):1197-204; quiz 204. doi: 10.1016/j.jvir.2010.04.018. J Vasc Interv Radiol. 2010. PMID: 20656222

7

Oxaliplatin-induced hepatoportal sclerosis, portal hypertension, and variceal bleeding successfully treated with transjugular intrahepatic portosystemic shunt.

Lawal TO, Farris AB, El-Rayes BF, Subramanian RM, Kim HS. Lawal TO, et al. Among authors: kim hs. Clin Colorectal Cancer. 2012 Sep;11(3):224-7. doi: 10.1016/j.clcc.2012.02.002. Epub 2012 Apr 25. Clin Colorectal Cancer. 2012. PMID: 22537609 No abstract available.

8

Prognostic value of 18f-fluorodeoxyglucose positron emission tomography-computed tomography in predicting survival in patients with unresectable metastatic melanoma to the liver undergoing yttrium-90 radioembolization.

Piduru SM, Schuster DM, Barron BJ, Dhanasekaran R, Lawson DH, Kim HS. Piduru SM, et al. Among authors: kim hs. J Vasc Interv Radiol. 2012 Jul;23(7):943-8. doi: 10.1016/j.jvir.2012.04.010. Epub 2012 May 19. J Vasc Interv Radiol. 2012. PMID: 22609292 Clinical Trial.

9

Safety and feasibility of same-day discharge of patients with unresectable hepatocellular carcinoma treated with doxorubicin drug-eluting bead transcatheter chemoembolization.

Prajapati HJ, Rafi S, El-Rayes BF, Kauh JS, Kooby DA, Kim HS. Prajapati HJ, et al. Among authors: kim hs. J Vasc Interv Radiol. 2012 Oct;23(10):1286-93.e1. doi: 10.1016/j.jvir.2012.07.003. J Vasc Interv Radiol. 2012. PMID: 22999748

10

mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE).

Prajapati HJ, Spivey JR, Hanish SI, El-Rayes BF, Kauh JS, Chen Z, Kim HS. Prajapati HJ, et al. Among authors: kim hs. Ann Oncol. 2013 Apr;24(4):965-73. doi: 10.1093/annonc/mds605. Epub 2012 Dec 5. Ann Oncol. 2013. PMID: 23223331 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,209 results

Search Page

Filters